Sign up today and learn more about Navigenics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Navigenics Stock
Navigenics, Inc. helps educate and empower individuals and their physicians with knowledge of their genetic predispositions, and then motivates them to act on the information to prevent the onset of disease, achieve earlier diagnosis, appropriately manage disease, or otherwise lessen its impact. Navigenics' lead investors are Kleiner Perkins Caufield and Byers, Sequoia Capital and MDV-Mohr Davidow Ventures.
David B. Agus
Co-Founder, Chief Science officer